Rossina Escobar Yanes, DDS | |
7365 Carnelian St, Ste 236, R Cucamonga, CA 91730 | |
(909) 466-4495 | |
(909) 466-4498 |
Full Name | Rossina Escobar Yanes |
---|---|
Gender | Female |
Speciality | Dentist |
Location | 7365 Carnelian St, R Cucamonga, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760696181 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 49308 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rossina Escobar Yanes, DDS 7365 Carnelian St, Ste 236, R Cucamonga, CA 91730 Ph: (909) 466-4495 | Rossina Escobar Yanes, DDS 7365 Carnelian St, Ste 236, R Cucamonga, CA 91730 Ph: (909) 466-4495 |
News Archive
The Wisconsin Next Generation Jobs Act, a bipartisan special legislative session bill submitted at the request of Governor Scott Walker, would provide investment capital and other types of funding to bioscience companies operating within the state.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.
In a study published today in the Nature Communications, researchers from King's College London have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections
› Verified 5 days ago